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Background. Pharmacopuncture is a new form of acupuncture combining acupuncture with herbal medicine, and it has been
used under various conditions in Korea. The aim of this study is to establish clinical evidence for the safety and efficacy of
pharmacopuncture in Korea. Methods. We searched 9 databases and two relevant journals up to December 2014 using keywords,
such as pharmacopuncture. All randomized, controlled trials evaluating pharmacopuncture under any conditions in Korea were
considered. Results. Twenty-nine studies involving 1,211 participants were included. A meta-analysis of two studies on obesity
showed that 5 to 8weeks of pharmacopuncture reducedweight, waist circumference, and bodymass index (BMI)more than normal
saline injections. In the 5 studies of musculoskeletal conditions, 7 to 30 days of pharmacopuncture had additional effects on the
reduction of pain intensity, and this benefit was maintained by limiting analyses to studies with a low risk of bias for randomization
and/or allocation concealment. Conclusions. This systematic review suggests the potential of pharmacopuncture for obesity and
musculoskeletal diseases. However, it is difficult to recommend pharmacopuncture as an evidence-based treatment because of
methodological flaws and small sample sizes of the included studies. Further well-designed trials are needed to draw a definitive
conclusion.
1. Introduction
Pharmacopuncture (herbal acupuncture) is a new form
of acupuncture treatment combining acupuncture and the
injection of herbal medicine to the acupuncture points
(acupoints). In Korea, pharmacopuncture was first officially
introduced to the traditional Korean medicine (TKM) com-
munity in 1967 by Sang-Cheon Nam.While the conventional
acupuncture treatment incorporates the physical stimulation
of associated meridians and acupoints, pharmacopuncture
adds chemical ingredients from therapeutic herbs with phar-
macological effects [1]. In the treatment of pharmacopunc-
ture, the typical constitution and conditions of the individual
patient are diagnosed, and specific amounts of herbal extracts
are injected into meridians and acupoints, providing the
effect of both acupuncture and herbal medicine [1].
The effects of pharmacopuncture can be immediately
observed after treatment because herbal extracts are directly
absorbed without the need to pass through the gastrointesti-
nal tract. Additionally, both patients with difficulty swallow-
ing and those who refuse to take herbal medicine may profit
by receiving pharmacopuncture treatment [1]. The major
benefits of pharmacopuncture in comparison to conventional
acupuncture are more rapid effects, additional synergistic
effects of acupuncture and herbal extracts, and the ease for
controlling dosage [2].
Since the 1970s, studies on pharmacopuncture conducted
mostly in animals have reported that Astragali Radix [3, 4],
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Angelica gigas [4], Cornus cervi Parvum [5], and Sorbus
commixta Hedl. extracts [6] were effective in pain control,
immune enhancement, obesity, and arthritis. Since the 2000s,
there are a growing number of clinical trials on pharmacop-
uncture. Currently, numerous types of pharmacopuncture
extracts are used. Pharmacopuncture is applied to treat
various disorders, most frequently for musculoskeletal con-
ditions. The effectiveness for these disorders has been well
studied [1, 7].
This systematic review aims to summarise existing results
of randomized controlled trials (RCTs) conducted in Korea
to establish the clinical evidence of the safety and efficacy of
pharmacopuncture for various conditions.
2. Methods
2.1. Data Sources and Searches. We searched PubMed, Ovid
Medline, and Korean databases, including the Oriental
Medicine Advanced Searching Integrated System (OASIS),
the Korean Studies Information Service System, RISS4U,
Korea Institute of Science and Technology Information,
KOREAMED, DBPIA, Korea National Assembly Library,
the Journal of Korean Pharmacopuncture Institute, and the
Journal of Korean Acupuncture and Moxibustion Medicine
Society from inception to December 2014. Reference lists of
reviews and relevant articles were examined for additional
studies.
The search terms used for PubMed were as follows:
(pharmacopuncture∗[All Fields] OR “herbal acupuncture”
[All Fields] OR “aqua acupuncture” [All Fields] OR
aquapuncture∗[All Fields] OR “acupoint injection” [All
Fields]) AND (“randomized controlled trial” [PT] OR
“controlled clinical trial” [PT] OR random∗[TIAB] OR
placebo [TIAB] OR “drug therapy” [Subheading] OR trial
[TIAB] OR groups [TIAB]) NOT Animals [MeSH] NOT
Humans [MeSH]. These search terms were slightly modified
for other databases. Trials conducted in Korea and published
in English or Korean were sought.
2.2. Study Selection
2.2.1. Inclusion Criteria. All RCTs evaluating pharmacop-
uncture treatment on various conditions were considered.
Studies enrolling participants who reported any disorder or
disease were eligible for inclusion. Hence, we classified each
disorder or disease according to the International Statistical
Classification of Diseases and Related Health Problems, 10th
revision (ICD-10) [8] for the analyses.
Studies which assessed the combined effects of pharma-
copuncture plus other interventions (e.g., pharmacopuncture
plus acupuncture) were also considered when the identical
intervention was administered to both the pharmacopunc-
ture group and the control group.
For control groups, we considered placebo or sham,
other interventions, and no interventions. Placebo or sham
interventions were injections of normal saline or distilled
water into the pharmacopuncture points or nonacupunc-
ture points. Other interventions included acupuncture,
herbal/western medicine, cupping, tuina, diet therapy, and
physical therapy, including hot pack, transcutaneous electri-
cal nerve stimulation (TENS), interferential current therapy
(ICT), ultrasound, massage, and exercise.
Therewas no restriction on the type of outcomemeasures,
but they had to be relevant to the conditions. All the trials
were conducted in Korea.
2.2.2. Exclusion Criteria. Nonrandomized trials, animal or
cell studies, literature research, and quasi-RCTs (methods of
allocating participants to a treatment group which are not
truly random, e.g., hospital record number or alternation,
and date of birth) were excluded. Trials including healthy
participants were excluded.
We did not include trials testing bee-venom pharmacop-
uncture or injection of conventional medicine because they
did not investigate the chemical effects of herbal medicine.
Trials comparing different types of pharmacopuncture were
excluded because the efficacy of control intervention could
not be determined.
2.3. Data Extraction. We reviewed all searched articles to
evaluate their eligibility for inclusion. In case of uncertainties,
authors were contacted for further information.
After the selection of studies, we extracted the following
data from the selected articles: author, year of publication,
study design, participants (age, gender), diseases or disor-
ders, pharmacopuncture intervention, control intervention,
outcomemeasures,main results, and adverse events (Table 1).
The outcomemeasures at the end of the treatments were used
in data pooling. As for the pharmacopuncture interventions,
we summarised each item in terms of the types and methods
of pharmacopuncture, regimen, pharmacopuncture points,
extractionmethods, types of syringe, and amount, depth, and
angle of the injection following STRICTA recommendations
and the data was modified into the suitable form for trials of
pharmacopuncture (Table 2).
2.4. Assessment of Risk of Bias (ROB). We evaluated the
ROB for the included studies according to the Cochrane
Collaboration’s ROB assessment tool [39].
We rated ROB for each item using “Yes (Y, low ROB),”
“Unclear (U, uncertain or unknown ROB),” or “No (N, high
ROB).” For patient blinding in studies with a placebo control,
we assessed the study as having a low ROB when it clearly
stated that patients were blinded. For the outcome assessor
blinding, we judged that if it was clearly reported that the
outcome assessor was blinded or the outcome measure was
evaluated by blinded participants only, it was rated as having a
low ROB. If the outcome measure was assessed by unblinded
participants only, we rated it as having a high ROB. If the
outcome measures were mixed with subjective and objective
assessments and we could not obviously judge whether the
outcome assessor was blinded or not, it was rated as having an
unclear ROB. As for the incomplete outcome data reporting
it was rated as having a low ROB if the number and reason
for attrition were clearly reported in each group and were
similar between groups and the percentage of withdrawals
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database searching (n = 5124)
removed (n = 3030)
eligibility (n = 101)
with reasons (n = 72)
(v) Full text not obtainable (n = 1)
(iv) Healthy volunteers (n = 5)
control group criteria (n = 7)
(iii) Not satisfying intervention or
Literature research (n = 1)
Animal study (n = 19)
(ii) No clinical study
(i) Nonrandomized trial (n = 39)
Figure 1: Flow diagram of literature search.
and drop-outs did not exceed 20% for short-term and 30%
for long-term follow-up [39]. If therewas disagreement, it was
resolved by discussion with HL and JIK.
2.5. Data Analyses. Meta-analysis was performed using the
Review Manager software (version 5.2 for Windows; the
Nordic Cochrane Centre, Copenhagen, Denmark). We used
the mean difference (MD) and 95% confidence intervals
(CI) to estimate the effect of an intervention for continuous
outcomes using a random-effects model.
If it was impossible to perform statistical pooling, studies
were assigned to 1 of 4 categories to classify the result for
interpretation. The comparison between two groups was
based on the results of original study: (1) positive when the
pharmacopuncture group was significantly better than the
control group, P; (2) negative when the control group was
significantly better than the pharmacopuncture group, N; (3)
neutral when there was no significant difference between the
groups, NS; and (4) not assessable when the results were
complicated or the presented data were insufficient, NA.
To address the heterogeneity among the included studies,
the 𝐼2 test was used. An 𝐼2 value of 50% or more was consid-
ered to be an indicator of a substantial level of heterogeneity
[40]. Sensitivity analyses were planned by including studies
with low ROBs only or by including pain-related studies with
sample sizes ≥40 per arm. We analyzed the trials with low
ROBs for randomization and/or allocation concealment only
and examined whether the estimate of the intervention effect
was affected [41, 42]. For the pain-related trials, studies with
≥40 participants per arm were separately analyzed to see
whether any differences in the estimate emerged [43].
3. Results
Our search terms yielded 5,124 records: 49 from Ovid
Medline or PubMed and 5,075 from domestic databases or
relevant journals. After duplicated studies were removed,
3,030 records were screened. Based on the title and abstract,
2,929 records were excluded; 687 articles were inappropriate
for the topic of this review; 2,105 were not clinical studies
or were nonrandomized trials; and 137 trials did not satisfy
the pharmacopuncture or control group criteria. Out of the
remaining 101 studies, a total of 29 RCTs (Korean: 𝑛 = 27;
English: 𝑛 = 2) were included in our review. Figure 1 shows
a flow diagram of the literature searching as recommended
in the Preferred Reporting Items for Systematic Reviews
and Meta-Analyses (PRISMA) [44]. Details of the included
studies are summarised in Table 1.
3.1. Participants. Overall included RCTs (29): data of 1,321
participants were included in the review. The number of
participants in each group ranged from 10 to 37 in the
pharmacopuncture group and from 9 to 46 in the control
group. The median sample sizes per arm were 17 in the
pharmacopuncture group and 18 in the control group.
The types of diseases/disorders were very heterogeneous.
Thus, we classified them using ICD-10 codes. The most
common disorders were diseases of the musculoskeletal
system and connective tissue (XIII, 𝑛 = 15). Among them,
there were 5 studies each for low back pain [25–27, 31, 33]
and cervicalgia [22–24, 28, 29]; two studies were for knee
osteoarthritis [30, 34] and shoulder pain [21, 35] each; and
one was for ankle sprain [32]. In the category nervous system
disease/disorder [12–17] (VI, 𝑛 = 6), three studies of Bell’s
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palsy [13, 14, 17], two of headache [12, 15], and one for carpal
tunnel syndrome [16] and leg spasticity of stroke patients
[18] were found. The other studies could be classified into
the endocrine, nutritional, and metabolic diseases [9–11] (IV,
𝑛 = 3), diseases of the digestive system [19, 20] (XI, 𝑛 = 2),
diseases of the circulatory system [18] (IX, 𝑛 = 1), diseases of
the genitourinary system [36] (XIV, 𝑛 = 1), and pregnancy,
childbirth, and the puerperium [37] (XV, 𝑛 = 1).
3.2. Pharmacopuncture Intervention. Details of pharmacop-
uncture interventions based on the revised STRICTA and
modified to suitable patterns for pharmacopuncture are
summarised in Table 2 [38].
3.2.1. Types of Pharmacopuncture. When pharmacopuncture
was classified by treatment rationale, meridian field phar-
macopuncture was practiced in four trials [12, 20, 26, 29],
eight-principle pharmacopuncture was administered in 14
studies [13–15, 21–25, 27, 28, 31–33, 35], mono-herbal-type
pharmacopuncture was used in nine trials [10, 16–19, 30, 34,
36, 37], and the other two studies could not be classified [9, 11].
The types of pharmacopuncture were highly variable. Out
of the 29 included studies, 12 tested monoherbal medicine
pharmacopuncture: six studies [17–19, 34, 36, 37] usedHomi-
nis Placenta; three studies [12, 20, 29] used Carthami-Semen;
and Capsicum frutescens L. [10], scolopendrid [16], and root
bark of Ulmus davidiana Planch. (UDP) [30] were used in
one study each. The other 17 tested mixed-herbal medicine
pharmacopuncture types: five studies [15, 22, 23, 25, 32] used
Hwangryunhaedok-tang (Scutellaria baicalensis, Coptis chi-
nensis, Phellodendron amurense, and Gardenia jasminoides);
four studies [13, 14, 28, 31] used Soyeom pharmacopunc-
ture (Taraxacum officinale, Lonicera japonica, Rehmannia
glutinosa, Forsythia viridissima, Coptis chinensis, Scutellaria
baicalensis, Phellodendron amurense, and Gardenia jasmi-
noides); another four studies [21, 24, 33, 35] used Ouhyul
pharmacopuncture (Gardenia jasminoides, Corydalis remota,
Boswellia carteri, Commiphora myrrha, Prunus persica, Paeo-
nia lactiflora, Salvia miltiorrhiza, and Caesalpinia sappan);
and each used Ephedra sinica Stapf andAconitum carmichaeli
Debx. [11], Calculus Bovis.Fel Ursi.Moschus (BUM) [26],
Panax ginseng plus BUM [9], and ShinBaro pharmacopunc-
ture (modification of Chungpa-Juhn (Saposhnikovia divari-
cata Schiskin, Achyranthes bidentata Blume, Acanthopanax
sessiliflorum Seem, Cibotium barometz J. Smith, Glycine max
Merrill, and Eucommia ulmoides Oliver)) [27].
3.2.2. Pharmacopuncture Methods. Participants received
fixed (i.e., all participants received the same treatment),
partially individualized (using a fixed set of points to be given
with a set of points to be used flexibly), or individualized
pharmacopuncture treatment (each participant received
a tailored treatment). Out of the 29 studies, 18 used
fixed [9–18, 20, 21, 25, 29, 32, 35–37], 7 studies used partially
individualized [19, 22, 23, 26, 28, 30, 34], and the other 4 trials
used individualized acupuncture treatments [24, 27, 31, 33].
3.2.3. Treatment Sessions. The number of pharmacopuncture
sessions ranged from 3 to 16 over 6 days to 8 weeks.
3.2.4. Pharmacopuncture Points. Regarding pharmacopunc-
ture points used in the studies, 19 studies [11–15, 17–23, 25,
27, 29, 31, 32, 36, 37] used 12 meridian points and/or extra
points. Four studies [26, 28, 30, 34] used 12 meridian points,
extra points, Ashi points, and tender points together. Two
studies [24, 33] usedAshi points only, and one study [35] used
12 meridian points plus Dr. Dong’s acupuncture point. Three
studies [9, 10, 16] mentioned approximate areas but not the
accurate points, such as the abdomen [10], the area between
the flexor carpi radialis tendon and the median nerve [16],
or the left and right sides of four points inferior to and four
points superior to the navel points on the stomach and the
spleen and gallbladder meridians [9].
3.2.5. Extraction Methods. As for the extraction methods
of pharmacopuncture, 6 studies [11, 13, 15, 21, 27, 30] used
distillation of the herbal medicine; three studies [12, 16,
20] used alcohol immersion extraction methods; one study
[29] used an extraction method that involved pressing from
the herbs; one study [9] used distillation for wild ginseng
and alcohol immersion for BUM; and the other 18 studies
did not report details about the extraction method. Out of
the 11 trials that mentioned extraction methods, 8 studies
[9, 11, 13, 15, 16, 21, 27, 29] followed the guidelines of the
Korean Pharmacopuncture Institute. Two studies that used
Carthami-Semen [12, 20] did not follow the guidelines, in
which the pressing extraction method is used to extract
Carthami-Semen, but used an alcohol immersion extraction
method instead. The other trial [30] used distillation to
extract UDP, but there was no guideline for the extraction of
UDP.
3.2.6. Types of Injector. In total, 24 studiesmentioned the type
of injector: 16 studies [13, 15–20, 24, 27–31, 35–37] used 1mL
syringes; one study [10] used a mesogun; and another study
[34] reported using a U-100 insulin syringe but did not state
the size or gauge of the syringe. The gauge, which indicates
the thickness of the needle, was varied. 18 studies stated the
gauge: four studies [15, 18, 21, 28] applied a 30-gauge syringe;
seven studies [17, 22, 23, 25, 30–32] were donewith a 29-gauge
syringe; two studies [12, 20] were performed with a 27-gauge
syringe; four studies [13, 27, 29, 37] were done using a 26-
gauge syringe; and one study [36] used a 26-gauge syringe
(CV4) and a 30-gauge syringe (ST36, SP6, and SP9) according
to the pharmacopuncture points. Five studies [9, 11, 14, 26, 33]
did not mention the gauge.
3.2.7. Amount of Injection. Each amount of injection ranged
from 0.05mL to 1mL, and the total amount of injection
ranged from 0.2mL to 5mL. Only one study [30] did not
report the amount of injection.
3.2.8. Depth of Injection. Seven studies [16, 18, 20, 27, 29, 30,
36] reported the depth of injection. The depth of injection
ranged from 5 to 30mm according to the pharmacopuncture
points.
3.2.9. Angle of Injection. The angle of injection was reported
in only three studies: two studies [18, 27] used perpendicular
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angles, and one study [16] used oblique angle (45 degrees)
when injecting into the wrist area.
3.3. Control Intervention. In this review, control procedures
were classified into four types. First, pharmacopuncture
was compared with normal saline [9–12, 15, 17, 20, 21, 30,
35–37] or distilled water injections [18] in 13 studies for
blinding. Secondly, pharmacopuncture was tested against
tuina manual treatment in three studies [23–25]. Thirdly,
three studies adopted acupuncture as a control group [19,
32, 34]. Finally, the comparison of pharmacopuncture plus
other interventions and other interventions alone groups was
investigated in ten studies [13, 14, 16, 22, 26–29, 31, 33]. Other
interventions included acupuncture [13, 14, 16, 22, 26–29, 31,
33], herbal/western medicine [13, 14, 16, 22, 27–29, 31, 33],
cupping [28, 31], tuina [27], and physical therapy [13, 14, 16,
27–29, 31, 33] (Table 1).
3.4. Outcome Measures. Outcome measures reported in the
included studies were very diverse because of the various
types of focused diseases. Intensity of discomfort (e.g.,
measured with the visual analogue scale, the numeric rating
scale) was investigated in 20 trials [13–16, 20–33, 35, 37]. All
studies focusing on diseases of the musculoskeletal system
and connective tissue adhered to it except one [34]. A quality-
of-life-related scale was applied in six studies [12, 15, 19, 20,
29, 30]. All trials on Bell’s palsy utilized the Yanagihara score
[13, 14, 17]. All studies on cervicalgia used a neck disability
index [22–24, 28, 29]. Out of the five studies that treated
low back pain, three studies were applied using the Oswestry
disability index [25–27] (Table 1).
3.5. ROB Assessment. The majority of the included trials
were assessed as having a high ROB. Details of the ROB
assessments are presented in Table 3.
Twelve out of the 25 studies reported adequatemethods of
sequence generation, such as using a random number table,
computer randomnumber generator, randomization code, or
coin toss [9, 11–13, 18, 20–22, 24, 27, 29, 36].Group assignment
was adequately concealed in only four trials using sealed
opaque envelopes [12, 30] or central allocation [21, 27].
The participant, practitioner, and outcome assessor each
were blinded in only two trials [12, 30]. Double-blinding
of the participant and practitioner was conducted in two
studies [18, 35]. Participant blinding was performed in four
trials [10, 11, 17, 37]. The participant and outcome assessor
were blinded in three trials [15, 20, 36] as outcome measures
were all subjective and assessed by blinded participants in
two trials [15, 36], and the other one mentioned that an
independent assessor evaluated constipation symptoms [20].
In terms of addressing incomplete outcome data, 13
studies [13–16, 19, 22–24, 27, 29, 31, 34, 36] were assessed as
having a lowROB, as they had nomissing outcome data. Nine
trials [9, 12, 18, 20, 21, 30, 32, 33, 35] had missing outcome
data, but the drop-out rate did not exceed 20% for short-
term and 30% for long-term follow-up, and the number and
reasons for drop-out in each group were similar. Six trials
[10, 11, 25, 26, 28, 37] also had missing outcome data, but the
drop-out rate exceeded 20% for short-term and 30% for long-
term follow-up. The other study [17] had missing outcome
data, but we could not calculate the drop-out rate, as the
number of participants randomized in each group was not
reported.
As for the selective outcome reporting, we could not
locate and compare the protocols of any of the included
studies.Therefore, we judged the ROB based on the described
methods in each study. One study [16] had a high ROB
because the authors (Lim et al.) were supposed to report
visual analog scale (VAS) in the methods part, but there was
no VAS data in results section.
3.6. Effects of Pharmacopuncture. Thekey outcomes from the
included studies are provided in Table 1.
Low back pain (𝑛 = 5) [25–27, 31, 33], cervicalgia (𝑛 = 5)
[22–24, 28, 29], obesity (𝑛 = 3) [9–11], and Bell’s palsy (𝑛 =
3) [13, 14, 17] were the most actively researched fields using
pharmacopuncture intervention.
A total of 10 studies were available for statistical pooling
(Figures 2 and 3). As for the other 19 trials in which
statistical pooling was impossible because of the substantial
heterogeneity of the diseases, types of pharmacopuncture,
control groups, or outcomemeasures, we classified the results
into four categories: positive (P), negative (N), neutral (NS),
and not assessable (NA).
3.6.1. Effects of Pharmacopuncture in Obesity. Among the
three studies on obesity, two studies [10, 11] showed that
Capsicum frutescens L. or Ephedra sinica Stapf-Aconitum
carmichaeli Debx. pharmacopuncture significantly reduced
weight, waist circumference, and BMI compared with
the normal saline injection group by 1.36 kg, 4.59 cm,
and 0.52 kg/m2, respectively, immediately after treatment
(Figure 2(a), MD 1.36, 95% CI: 0.51–2.21; Figure 2(b), MD
4.59, 95% CI: 2.63–6.55; Figure 2(c), MD 0.52, 95% CI: 0.19–
0.85). There were no significant heterogeneities among the
trials (Figure 2(a), 𝜒2 = 1.16, degrees of freedom (df) = 1, 𝑝 =
0.28, and 𝐼2 = 14%; Figure 2(b), 𝜒2 = 1.27, df = 1, 𝑝 = 0.26,
and 𝐼2 = 21%; Figure 2(c), 𝜒2 = 0.35, df = 1, 𝑝 = 0.55, and
𝐼
2 = 0%). Another study [9] also reported that body weight,
waist circumference, and BMI were more reduced than in the
normal saline group, but we did not obtain sufficient data for
statistical pooling. Thus, the result was not assessable.
3.6.2. Effects of Pharmacopuncture on Musculoskeletal Con-
ditions. In five studies on musculoskeletal diseases [22, 26–
29], pharmacopuncture plus other interventions significantly
alleviated pain intensity compared with the other interven-
tions only immediately after treatment (Figure 3(a), MD 1.38,
95% CI: 0.96–1.79, and 𝐼2 = 10%). Three studies that com-
pared pharmacopuncture with tuina manual therapy [23–25]
reported that pharmacopuncture was not more effective than
tuina inmusculoskeletal diseases immediately after treatment
(Figure 3(b), MD 0.36, 95% CI: −0.10–0.81, and 𝐼2 = 15%).
As statistical pooling was impossible in the other seven
trials, detailed results were described as follows. Two trials
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∗Based on the guidelines from the Cochrane Back Review Group [39]; “Y” indicates “yes (low risk of bias)”; “U,” “unclear”; “N,” “no (high risk of bias).”
on HNP of the L-spine [31, 33] showed unassessable effects of
Soyeom and Ouhyul pharmacopuncture. Of the two studies
on osteoarthritis of the knee, one study [30] contrasted root
bark of UDP pharmacopuncture with normal saline injec-
tion, and the effect was not assessable. Another study [34]
that compared Hominis Placenta Pharmacopuncture with
acupuncture showed no significant difference between the
groups. In shoulder pain caused by stroke [21, 35], the effect
of pharmacopuncture was not assessable. For acute ankle
sprain [32], acupuncture improved the symptoms better than
Hwangryunhaedok-tang pharmacopuncture after 9–12 days
of treatments; in other words, they reported a negative effect
of pharmacopuncture.
3.6.3. Effects of Pharmacopuncture on Diseases of the Nervous
System. The results of pharmacopuncture were compos-
ited for each disease. For headache, both Carthami-Semen
and Hwangryunhaedok-tang pharmacopuncture improved
symptoms compared with normal saline injection [12, 15].
For Bell’s palsy, the effect of Hominis Placenta Pharmacop-
uncture was significantly better than normal saline injection
[17]. However, for the postauricular pain that accompanies
Bell’s palsy, the effect of Soyeom pharmacopuncture was
not assessable. It may be due to the fact that the pain
intensity or duration of pain decreased significantly, while
the Yanagihara score did not show a significant difference
between the groups [13, 14]. One study on scolopendrid
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(c) Pharmacopuncture versus normal saline: BMI decrement (kg/m2)
Figure 2: Effect of pharmacopuncture in obesity. BMI: body mass index; CI: confidence intervals; SD: standard deviation.
pharmacopuncture treatment did not show additional effects
on pain intensity in carpal tunnel syndrome [16].
3.6.4. Effects of Pharmacopuncture on Diseases of the Circula-
tory System. The effect of Hominis Placenta Pharmacopunc-
ture compared with distilled water injection was not assess-
able in leg spasticity of stroke patients due to the complexity of
the results. Formodified Ashworth scale (MAS), H-reflex/M-
response ratio (H/M ratio), and Berge balance scale (BBS),
there were no significant differences between groups, while
the time up and go (TUG) in pharmacopuncture group was
significantly lower than in distilledwater injection group [18].
3.6.5. Effects of Pharmacopuncture on Diseases of the Digestive
System. One study of Hominis Placenta Pharmacopuncture
had a similar effect to acupuncture in dyspepsia [19]. The
effect of Carthami-Semen pharmacopuncture on chronic
constipation was not assessable [20].
3.6.6. Effects of Pharmacopuncture on Diseases of the Gen-
itourinary System. One study on Hominis Placenta Phar-
macopuncture for dysmenorrhea showed a similar effect to
normal saline injection [36].
3.6.7. Effects of Pharmacopuncture on Pregnancy, Childbirth,
and the Puerperium. Hominis Placenta Pharmacopuncture
had complicated results compared with normal saline injec-
tion [37]. There were no significant differences between
groups in VAS for heating feeling, sweet during movement
and sleeping, and complete blood cell (CBC) count. For
thirst, Hominis Placenta Pharmacopuncture group showed
significant higher VAS than normal saline injection group
before the treatment (𝑝 = 0.023). After treatment, two
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(b) Pharmacopuncture versus tuina: VAS score
Figure 3: Effects of pharmacopuncture on musculoskeletal conditions. CI: confidence intervals; SD: standard deviation; VAS: visual analog
scale.
groups reported similar thirst symptom (𝑝 = 0.510) without
correcting the baseline value. Therefore, we could not assess
the results.
3.7. Adverse Events (AEs). Only five studies reported AEs. In
the study by Seo [21], they compared Ouhyul pharmacop-
uncture with normal saline and reported general pain in the
Ouhyul group and transient local site pain or fatigue in the
normal saline group. Kim [10] comparedCapsicum frutescens
L. with normal saline and reported moderate AEs related to
anesthesia cream or pharmacopuncture (4 in the Capsicum
frutescens L. group, 2 in the normal saline group). In each
of the two studies by Park et al. [12, 20], they compared
Carthami-Semen with normal saline and reported mild AEs,
such as pain during the injection, ecchymosis, and redness
in the Carthami-Semen group and moderate pain during the
injection in the normal saline group. One study by Kim et al.
[30] compared UDP with normal saline and reported mild
AEs, such as nausea and itching in the UDP group and slight
dizziness in the normal saline group. These AEs disappeared
in a short timewithout specific treatment, and no serious AEs
were reported. Another two studies by Jun et al. [27] and Kim
et al. [37] reported that AEs did not occur, and the other 22
trials [9, 11, 13–19, 22–26, 28, 29, 31–36] did not mention AEs.
3.8. Sensitivity Analyses. We performed sensitivity analyses
by excluding studies with predefined less desirable character-
istics, and the results from the musculoskeletal studies were
robust.
3.8.1. ROB. When the analyses were limited to two studies
with a low ROB for random sequence generation and/or
allocation concealment [27, 29], pharmacopuncture had
additional benefits in terms of pain relief in musculoskeletal
diseases immediately after treatments (MD 1.76, 95% CI:
0.80–2.71, 𝐼2 = 0%). One study with adequate random
sequence generation and/or allocation concealment did not
provide enough information; thus, the effect of pharmacop-
uncture compared with normal saline could not be assessed
in shoulder pain caused by stroke [21].
3.8.2. Sample Size. There was no study with ≥40 participants
per arm.
4. Discussion
Our review on pharmacopuncture aimed to establish the
evidence of pharmacopuncture treatment of any disease. The
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analyses of two trials on obesity [10, 11] demonstrated a sig-
nificant benefit from 5 to 8 weeks of pharmacopuncture treat-
ments comparedwith normal saline injection.The analyses of
five trials onmusculoskeletal diseases [22, 26–29] represented
a significant effect from 7 to 30 days of combined treatment of
pharmacopuncture with other interventions (e.g., acupunc-
ture, herb medicine, tuina, and physical therapy) compared
with other interventions only. However, these analyses were
based on small studies and other interventions used in these
trials were varied; thus cautious interpretation is needed.
In themusculoskeletal diseases, pharmacopuncture’s benefits
were maintained by limiting the analyses to studies with a
low ROB for randomization and/or allocation concealment
[27, 29], which means that they presented robust evidence
for the treatment of musculoskeletal diseases. However, the
number of participants in these studies was too small (less
than 10 per arm), so careful interpretation is required.
Pharmacopuncture does not appear to be associated with
serious AEs, but the evidence is limited.
Most of the included studies had methodological weak-
nesses. Thirteen out of 25 studies [9, 11–13, 18, 20–22, 24,
27, 29, 30, 36] had low ROBs for adequate randomization
and/or allocation concealment. Among them, only three
studies [12, 21, 27] had both appropriate randomization and
allocation concealment. It is well known that inadequate
allocation concealment/random sequence generation leads to
the overestimation of treatment effects [41, 42], and uncon-
cealed allocation is themost important source of bias in RCTs
[45]. When we limited our analyses to the studies rated as
having low ROBs for randomization/allocation concealment,
pharmacopuncture’s benefit was maintained.
There were some limitations in this review. Our review
only included trials conducted in Korea and published in
Korean or English. Therefore, we could not necessarily
remove a potential language bias. Egger et al. [46] reported
that studies published in non-English languages or studies
published in journals that are not indexed in Medline are
likely to increase the effect estimates, and this may have
relevance to this review. In addition, pharmacopuncture, an
acupuncture-related intervention, may be highly culture spe-
cific. According to the 2007NationalHealth Interview Survey
(NHIS) data, only 6.5% of the Americans reported ever
receiving acupuncture [47]. Upchurch et al. also reported that
there was significant difference in the use of acupuncture
by ethnicity and race. Asian women reported the highest
usage [48]. Thus, further research is necessary to determine
whether the interventions are applicable and acceptable in
other countries.
The included trials were mostly of poor quality; thus,
the reported data are likely to be overestimated. In addition,
most of the included studies were small. Median sample sizes
per arm were 17 in the pharmacopuncture group and 18
in the control group. The effect size of small studies may
have been inflated due to poor methodological design and
conduct [49]. Moore et al. [43] reported in a simulation study
that at least 40 participants per arm are required to obtain
clinically relevant results in trials of pain; however, there were
no studies with ≥40 participants per arm, and we could not
analyze it separately.
The efficacy of the treatment used for the control group,
such as acupuncture, herbal medicine, and tuina manual
therapy, was not yet established; therefore, we could not
attribute “positive” results solely to the effectiveness of phar-
macopuncture. Additionally, clinically meaningful informa-
tion on follow-up results was sparse in the majority of the
included trials.Therefore, the available evidence prevented us
from further examining how long its benefit was maintained.
As we included all conditions/diseases, the focus of our
review may seem blurred. However, this review provides an
overview of the entire primary pharmacopuncture researches
conducted in Korea. The results help to set priorities and
directions for future research on pharmacopuncture.
Although this review represented the applicability of
pharmacopuncture, the standardisation of pharmacopunc-
ture intervention was not performed. Thus, in the future, it
is absolutely necessary to standardise it to apply pharmacop-
uncture in routine clinical practice. The degree of pharma-
copuncture stimulation could be influenced by the follow-
ing factors: (1) pharmacopuncture types; (2) concentration
and extraction methods of pharmacopuncture; (3) amount,
depth, and angle of injection; (4) syringe types, including
thickness and length; (5) pharmacopuncture points; and (6)
number of sessions based on the STRICTA guidelines [38].
Currently, the Korean Pharmacopuncture Institute suggests
guidelines for pharmacopuncture treatment. The classifica-
tion of pharmacopuncture, such as meridian field, eight-
principle, or monoherbal medicine-type, is determined by
the diagnosis of patient’s conditions. The total amount of
injections depends on the severity of the disorder, the age
of the patient, the injecting area, and the characteristics
and concentration of the pharmacopuncture extract. Using
various types of injectors or syringes depends on the type
of pharmacopuncture, its dosage, the area of the body part,
and the depth of the injection. Syringe needles are generally
between 26 and 32 gauges. Different needles are utilized for
different uses.
However, the standardisation of these factors has yet to
be completed, and there is no firmly established research
method for pharmacopuncture studies; therefore, pharma-
copuncture interventions of the included trials were very
heterogeneous. In addition, future studies should include not
only a test of the efficacy and safety of pharmacopuncture but
also an examination of the validity of the intervention based
on the standardised guidelines.
5. Conclusions
The results of this review demonstrate the effectiveness of
pharmacopuncture for the treatment of obesity and muscu-
loskeletal diseases compared with normal saline injections
and other interventions, respectively; however, given the
methodological flaws and small sample sizes, the available
evidence is insufficient to recommend pharmacopuncture
as an evidence-based treatment option. In the future, the
standardisation of pharmacopuncture intervention and the
adequate reporting of pharmacopuncture intervention in
accordance with STRICTA guidelines are needed.
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[42] J. Pildal, A. Hróbjartsson, K. J. Jörgensen, J. Hilden, D. G. Alt-
man, and P. C. Gøtzsche, “Impact of allocation concealment on
conclusions drawn from meta-analyses of randomized trials,”
International Journal of Epidemiology, vol. 36, no. 4, pp. 847–857,
2007.
[43] R. A. Moore, D. Gavaghan, M. R. Tramèr, S. L. Collins, and H. J.
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